Fortress Biotech (FBIO) vs Verrica Pharmaceuticals (VRCA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Verrica Pharmaceuticals (VRCA) has outperformed Fortress Biotech (FBIO) over the past year, losing 10.2% versus a loss of 33.1%. Over five years, FBIO leads with a -95.6% price change compared with -96.9% for VRCA. Verrica Pharmaceuticals is the larger company by market cap ($71.1 million vs $68.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FBIO | VRCA |
|---|---|---|
| Share price | $2.06 | $4.14 |
| Market cap | $68.54M | $71.12M |
| 1-day change | +0.74% | 0.00% |
| YTD return | -44.26% | -50.18% |
| 1-year return | -33.11% | -10.20% |
| 5-year return | -95.58% | -96.90% |
| P/E ratio (TTM) | 0.74 | — |
| EPS (TTM) | $2.76 | $-1.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.53 | $9.82 |
| 52-week low | $2.00 | $3.28 |
| Distance from 52-week high | -54.64% | -57.85% |
| Average volume | 507.86K | 62.53K |
| Shares outstanding | 33.35M | 17.18M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VRCA has outperformed FBIO by 22.9 percentage points over the past year.
FBIO vs VRCA FAQ
Which is bigger, Fortress Biotech or Verrica Pharmaceuticals?
Verrica Pharmaceuticals (VRCA) is larger, with a market capitalization of $71.12M compared with $68.54M for Fortress Biotech (FBIO).
Which stock has performed better over the past year, FBIO or VRCA?
VRCA returned -10.20% over the past 12 months, compared with -33.11% for FBIO (price return, excluding dividends). Past performance does not predict future results.
Are Fortress Biotech and Verrica Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.